Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions.
Saved in:
| Title: | Safety and efficacy of recombinant and live herpes zoster vaccines for prevention in at-risk adults with chronic diseases and immunocompromising conditions. |
|---|---|
| Authors: | Sullivan, Keith M.1 (AUTHOR) keith.sullivan@duke.edu, Farraye, Francis A.2 (AUTHOR) farraye.francis@mayo.edu, Winthrop, Kevin L.3 (AUTHOR) winthrop@ohsu.edu, Willer, David O.1,4 (AUTHOR) david.o.willer@gsk.com, Vink, Peter5 (AUTHOR) peter.e.vink@gsk.com, Tavares-Da-Silva, Fernanda1,6 (AUTHOR) fernanda.tavares1@organon.com |
| Source: | Vaccine. Jan2023, Vol. 41 Issue 1, p36-48. 13p. |
| Database: | Environment Complete |
| ISSN: | 0264410X |
|---|---|
| DOI: | 10.1016/j.vaccine.2022.10.063 |
